Ohio Public Employees Retirement System (OPERS)
STOK icon

Ohio Public Employees Retirement System (OPERS)’s Stoke Therapeutics STOK Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,283
Closed -$90.9K – 2014
2023
Q4 		$90.9K Buy
17,283
+948
+6% +$4.05K ﹤0.01% 1440
2023
Q3 		$64K Buy
+16,335
New +$107K ﹤0.01% 1491

Other funds holding STOK

ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s STOK Position: Q1 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Stoke Therapeutics (STOK) in Q1 2024, closing a stake of 17,283 shares — an estimated $90.9K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in STOK in Q3 2023 and held it in 2 quarters. The position peaked at $90.9K in Q4 2023. 103 funds tracked by Wall St. Rank hold STOK as of Q1 2024.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Stoke Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 17,283 Stoke Therapeutics shares in Q1 2024, an estimated $90.9K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Stoke Therapeutics in Q3 2023 and held it in 2 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Stoke Therapeutics position peaked at $90.9K in Q4 2023.
  • 103 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2024, filed 15 May 2024.